Clinical Trial Update: A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated Pain [Phase 2]

View source ↗

Summary

A Phase IIa clinical study evaluating the efficacy and safety of GenSci048 in patients with moderate to severe endometriosis-associated pain, currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• GenSci048 (GenSci048)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Endometriosis-related Pain | Phase 2 | Status: RECRUITING